milrinone has been researched along with Kidney Failure in 5 studies
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to test a proposed dose modification for intravenous milrinone in congestive heart failure patients (CHF, NYHA I-II) with either moderate or severe renal impairment." | 9.08 | Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure. ( Fox, PA; Greenslade, D; Hegbrant, J; Lasher, K; Lendrem, DW; Lockwood, GF; Rogers, J; Thysell, H; Woolfrey, SG, 1995) |
| "This study was designed to test a proposed dose modification for intravenous milrinone in congestive heart failure patients (CHF, NYHA I-II) with either moderate or severe renal impairment." | 5.08 | Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure. ( Fox, PA; Greenslade, D; Hegbrant, J; Lasher, K; Lendrem, DW; Lockwood, GF; Rogers, J; Thysell, H; Woolfrey, SG, 1995) |
| "Milrinone was continuously infused at a rate of 0." | 1.35 | Correlation between plasma milrinone concentration and renal function in patients with cardiac disease. ( Fujino, Y; Hasei, M; Mashimo, T; Nishimura, M; Uchiyama, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehanna, OM | 1 |
| El Askary, A | 1 |
| Al-Shehri, S | 1 |
| El-Esawy, B | 1 |
| Groninger, H | 1 |
| Kelemen, A | 1 |
| Ruiz, G | 1 |
| Tobias, JD | 1 |
| Hasei, M | 1 |
| Uchiyama, A | 1 |
| Nishimura, M | 1 |
| Mashimo, T | 1 |
| Fujino, Y | 1 |
| Woolfrey, SG | 1 |
| Hegbrant, J | 1 |
| Thysell, H | 1 |
| Fox, PA | 1 |
| Lendrem, DW | 1 |
| Lockwood, GF | 1 |
| Lasher, K | 1 |
| Rogers, J | 1 |
| Greenslade, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure[NCT01971944] | 50 participants (Actual) | Observational | 2010-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for milrinone and Kidney Failure
| Article | Year |
|---|---|
Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure.
Topics: Adult; Aged; Cardiotonic Agents; Chromatography, High Pressure Liquid; Chromium; Edetic Acid; Female | 1995 |
4 other studies available for milrinone and Kidney Failure
| Article | Year |
|---|---|
Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hyperglycemia; Hypog | 2018 |
A PIECE OF MY MIND. "Vote for Me".
Topics: Cardiotonic Agents; Communication; Decision Making; Family; Heart Failure; Heart-Assist Devices; Hum | 2016 |
Hemolytic-uremic syndrome and myocardial dysfunction in a 9-month-old boy.
Topics: Anemia; Anti-Bacterial Agents; Cardiomyopathies; Cardiotonic Agents; Dopamine; Electrocardiography; | 2007 |
Correlation between plasma milrinone concentration and renal function in patients with cardiac disease.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Creatinine; Female; Heart Diseases; Humans; Infu | 2008 |